LLY

917.46

+0.11%↑

JNJ

237.66

+0.19%↑

ABBV

206.13

-1.03%↓

NVS

148.1

-1.11%↓

AZN

188.8

+0.2%↑

LLY

917.46

+0.11%↑

JNJ

237.66

+0.19%↑

ABBV

206.13

-1.03%↓

NVS

148.1

-1.11%↓

AZN

188.8

+0.2%↑

LLY

917.46

+0.11%↑

JNJ

237.66

+0.19%↑

ABBV

206.13

-1.03%↓

NVS

148.1

-1.11%↓

AZN

188.8

+0.2%↑

LLY

917.46

+0.11%↑

JNJ

237.66

+0.19%↑

ABBV

206.13

-1.03%↓

NVS

148.1

-1.11%↓

AZN

188.8

+0.2%↑

LLY

917.46

+0.11%↑

JNJ

237.66

+0.19%↑

ABBV

206.13

-1.03%↓

NVS

148.1

-1.11%↓

AZN

188.8

+0.2%↑

Search

Quanterix Corp

Slēgts

SektorsVeselības aprūpe

4.4 -2.87

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

4.33

Max

4.52

Galvenie mērījumi

By Trading Economics

Ienākumi

10M

-23M

Pārdošana

3.7M

44M

Peļņas marža

-52.712

Darbinieki

450

EBITDA

15M

-17M

Rekomendācijas

By TipRanks

Rekomendācijas

Neitrāls

Prognoze 12 mēnešiem

+65.93% upside

Dividendes

By Dow Jones

Nākamie ieņēmumi

2026. g. 11. maijs

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

-75M

221M

Iepriekšējā atvēršanas cena

7.27

Iepriekšējā slēgšanas cena

4.4

Ziņu noskaņojums

By Acuity

35%

65%

112 / 351 Rangs Healthcare

Tehniskais rādītājs

By Trading Central

Pārliecība

Neutral Evidence

Quanterix Corp Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 18. marts 22:51 UTC

Peļņas

AIA Group Value of New Business Rose in 2025, Plans $1.7 Billion New Share Buyback

2026. g. 18. marts 21:40 UTC

Iegādes, apvienošanās, pārņemšana

Constellation Energy to Sell Portfolio of Assets for $5 Billion to Satisfy Regulators

2026. g. 18. marts 20:31 UTC

Peļņas

Micron 2Q Sales Nearly Triple Amid Tight Memory Supply

2026. g. 18. marts 23:49 UTC

Tirgus saruna
Galvenie ziņu notikumi

Nikkei May Fall on Renewed Concerns About Higher Energy Prices -- Market Talk

2026. g. 18. marts 23:31 UTC

Tirgus saruna

Gold Rises on Likely Technical Recovery -- Market Talk

2026. g. 18. marts 22:49 UTC

Tirgus saruna

New Zealand's Economic Recovery Has Yet to Find Footing -- Market Talk

2026. g. 18. marts 22:41 UTC

Tirgus saruna

Woodside Energy Opts for 'Safe, Experienced' Choice as CEO -- Market Talk

2026. g. 18. marts 22:36 UTC

Peļņas

AIA Group Value of New Business Rose in 2025, Plans $1.7B New Share Buyback

2026. g. 18. marts 22:24 UTC

Peļņas

AIA Group Announces New Share Buyback of $1.7B >1299.HK

2026. g. 18. marts 22:23 UTC

Peļņas

AIA Group 2025 Value of New Business Margin Was 58.5%, Up 3.6 Ppt on Year >1299.HK

2026. g. 18. marts 22:23 UTC

Peļņas

AIA Group 2025 Value of New Business $5.52B Vs. $4.71B >1299.HK

2026. g. 18. marts 21:58 UTC

Peļņas

Micron Sales Nearly Triple Amid Tight Memory Supply -- Update

2026. g. 18. marts 21:55 UTC

Tirgus saruna
Peļņas

Global Equities Roundup: Market Talk

2026. g. 18. marts 21:55 UTC

Tirgus saruna
Peļņas

Micron's Phone, PC Business Could Shrink Due to Memory Shortage -- Market Talk

2026. g. 18. marts 21:40 UTC

Tirgus saruna

Fuel Price Rise Equates to 20 Bps Rate Hike on Australian Households -- Market Talk

2026. g. 18. marts 21:16 UTC

Tirgus saruna

More Procter & Gamble Alumni Join Strobel at Coty -- Market Talk

2026. g. 18. marts 21:00 UTC

Galvenie ziņu notikumi

Iran War Puts Pressure on Japan's Economy. Takaichi Is In a Bind. -- Barrons.com

2026. g. 18. marts 20:58 UTC

Peļņas

Micron 2Q Gross Margin Nearly Doubled Due to Higher Pricing, CFO Says

2026. g. 18. marts 20:41 UTC

Peļņas

Micron Reports Extraordinary Earnings. Its Growth Is Accelerating. -- Barrons.com

2026. g. 18. marts 20:29 UTC

Peļņas

Micron Reports Extraordinary Earnings. Its Growth Is Accelerating. -- Barrons.com

2026. g. 18. marts 20:25 UTC

Peļņas

Micron Reports Extraordinary Earnings. Its Growth Is Accelerating. -- Barrons.com

2026. g. 18. marts 20:17 UTC

Peļņas

These Stocks Are Today's Movers: Micron, Swarmer, Lumentum, Trade Desk, Macy's, Williams-Sonoma, and More -- Barrons.com

2026. g. 18. marts 20:14 UTC

Tirgus saruna

Airlines Can't Offset Higher Fuel Prices for Long -- Market Talk

2026. g. 18. marts 20:09 UTC

Peļņas

Micron Reports Extraordinary Earnings. The Stock Is Up. -- Barrons.com

2026. g. 18. marts 20:07 UTC

Peļņas

Micron Technology Raises Qtr Dividend to 15c Vs. 11.5c >MU

2026. g. 18. marts 20:06 UTC

Peļņas

Micron Technology Board Has Approved 30% Increase in Qtrly Div >MU

2026. g. 18. marts 20:04 UTC

Peļņas

Micron Technology 2Q Operating Cash Flow $11.9 B >MU

2026. g. 18. marts 20:04 UTC

Peļņas

Micron Technology Sees 3Q Operating Expenses About $1.6 B >MU

2026. g. 18. marts 20:04 UTC

Peļņas

Micron Technology Sees 3Q Gross Margin About 81% >MU

2026. g. 18. marts 20:03 UTC

Peļņas

Micron Technology Sees 3Q Adj EPS $19.15 +/- 40c >MU

Salīdzinājums

Cenas izmaiņa

Quanterix Corp Prognoze

Cenas mērķis

By TipRanks

65.93% augšup

Prognoze 12 mēnešiem

Vidējais 7.5 USD  65.93%

Augstākais 8 USD

Zemākais 7 USD

Pamatojoties uz 2 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Quanterix Corp — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Neitrāls

2 ratings

0

Pirkt

2

Turēt

0

Pārdot

Tehniskais rādītājs

By Trading Central

5.34 / 6.015Atbalsts un pretestība

Īstermiņā

Neutral Evidence

Vidējā termiņā

Bullish Evidence

Ilgtermiņā

No Evidence

Noskaņojums

By Acuity

112 / 351 Rangs Veselības aprūpe

Ziņu noskaņojums

Liecība "Buļļu" tendencei

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Virs vidējā

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Quanterix Corp

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, it offers contract research services, including sample testing, homebrew assay development, custom assay development, lucent diagnostic, and LDT testing services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.
help-icon Live chat